Annual Cash & Cash Equivalents
$34.62 M
-$19.16 M-35.63%
31 March 2024
Summary:
LakeShore Biopharma annual cash & cash equivalents is currently $34.62 million, with the most recent change of -$19.16 million (-35.63%) on 31 March 2024. During the last 3 years, it has fallen by -$24.70 million (-41.64%). LSB annual cash & cash equivalents is now -41.64% below its all-time high of $59.32 million, reached on 01 March 2021.LSB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$35.62 M
+$22.56 M+172.72%
30 September 2023
Summary:
LakeShore Biopharma quarterly cash and cash equivalents is currently $35.62 million, with the most recent change of +$22.56 million (+172.72%) on 30 September 2023. LSB quarterly cash and cash equivalents is now -16.45% below its all-time high of $42.64 million, reached on 01 March 2022.LSB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LSB Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.6% | - |
| 3 y3 years | -41.6% | - |
| 5 y5 years | - | - |
LSB Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -41.6% | at low | -16.4% | +172.7% |
| 5 y | 5 years | -41.6% | at low | -16.4% | +172.7% |
| alltime | all time | -41.6% | at low | -16.4% | +172.7% |
LakeShore Biopharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | $34.62 M(-35.6%) | - |
| Sept 2023 | - | $35.62 M(+172.7%) |
| June 2023 | - | $13.06 M |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | $53.78 M(+26.1%) | - |
| Sept 2022 | - | $31.82 M(-25.4%) |
| Mar 2022 | $42.64 M(-28.1%) | $42.64 M |
| Mar 2021 | $59.32 M | - |
FAQ
- What is LakeShore Biopharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for LakeShore Biopharma?
- What is LakeShore Biopharma annual cash & cash equivalents year-on-year change?
- What is LakeShore Biopharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for LakeShore Biopharma?
What is LakeShore Biopharma annual cash & cash equivalents?
The current annual cash & cash equivalents of LSB is $34.62 M
What is the all time high annual cash & cash equivalents for LakeShore Biopharma?
LakeShore Biopharma all-time high annual cash & cash equivalents is $59.32 M
What is LakeShore Biopharma annual cash & cash equivalents year-on-year change?
Over the past year, LSB annual cash & cash equivalents has changed by -$19.16 M (-35.63%)
What is LakeShore Biopharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of LSB is $35.62 M
What is the all time high quarterly cash and cash equivalents for LakeShore Biopharma?
LakeShore Biopharma all-time high quarterly cash and cash equivalents is $42.64 M